Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ALBIREO PHARMA, INC. (ALBO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Sep-30-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenue:          
Revenue  40.68.39.612.70.011.4 5.1
            Revenue growth  388.4%-13.8%-24.4%1273900.0%-100.0%122.9%  
Cost and operating expenses:          
Cost of product revenue  1.4       
Research and development  82.576.845.631.713.08.13.75.6
Selling, general and administrative  69.642.4      
Other operating expense, net  10.6-14.62.20.8-3.7-0.2 -0.3
    Operating loss  -123.5-96.3-61.1-37.9-24.6-12.314.0-4.7
            Operating margin  -304.3%-1158.8%-634.2%-297.4%-2457700.0%-108.2% -92.7%
   
Other (loss) income:          
Gain from sale of priority review voucher, net of transaction costs  103.4       
Interest expense, net  -13.9-11.4-5.3-4.80.0-1.3-0.3-1.7
    Net (loss) income before income taxes  -34.0-107.6-62.7-46.1-24.2-16.313.7-6.8
Provision for income taxes     0.0-0.2-0.1-0.1 
    Net (loss) income  -34.0-107.6-62.7-46.1-24.4-16.4-13.8-6.8
   
Net (loss) income per share attributable to holders of common stock:          
Basic (in dollars per share)  ($1.77)($6.73)($5.04)($3.94)($3.12)($13.19)($6.45)($25.49)
Diluted (in dollars per share)  ($1.77)($6.73)($5.04)($3.94)($3.12)($13.19)($6.45)($25.49)
   
Weighted-average common shares outstanding:          
Basic (in shares)  19.216.012.411.77.81.22.10.3
Diluted (in shares)  19.216.012.411.77.81.22.10.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy